ProfileGDS4718 / 205757_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 92% 72% 94% 88% 69% 61% 90% 92% 92% 90% 91% 70% 61% 67% 85% 91% 77% 62% 64% 92% 91% 93% 93% 88% 68% 92% 62% 92% 67% 79% 65% 91% 89% 55% 57% 81% 88% 93% 48% 92% 72% 75% 67% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6344292
GSM549102patient 115, normal, homogenized [OPG study]9.5429292
GSM549104patient 119, normal, homogenized [OPG study]7.1151172
GSM549108patient 138, normal, homogenized [OPG study]9.9938294
GSM549119patient 077, normal, homogenized [OPG study]8.8925288
GSM549133patient 032, cancer, homogenized [OPG study]6.8773169
GSM549139patient 042, cancer, homogenized [OPG study]6.1963661
GSM549099patient 107, normal, homogenized [OPG study]9.1760390
GSM549109patient 139, normal, homogenized [OPG study]9.5800192
GSM549110patient 046, normal, homogenized [OPG study]9.6172192
GSM549114patient 063, normal, homogenized [OPG study]9.3980390
GSM549122patient 082, normal, homogenized [OPG study]9.3470991
GSM549134patient 033, cancer, homogenized [OPG study]6.9055870
GSM549136patient 036, cancer, homogenized [OPG study]6.2026461
GSM549140patient 044, cancer, homogenized [OPG study]6.6507167
GSM549111patient 047, normal, homogenized [OPG study]8.4932485
GSM549113patient 057, normal, homogenized [OPG study]9.5845691
GSM549132patient 031, cancer, homogenized [OPG study]7.516377
GSM549137patient 038, cancer, homogenized [OPG study]6.2501562
GSM549142patient 047, cancer, homogenized [OPG study]6.4620464
GSM549100patient 110, normal, homogenized [OPG study]9.5647792
GSM549107patient 135, normal, homogenized [OPG study]9.5287791
GSM549115patient 068, normal, homogenized [OPG study]10.004793
GSM549116patient 072, normal, homogenized [OPG study]9.805693
GSM549120patient 078, normal, homogenized [OPG study]8.9229888
GSM549131patient 030, cancer, homogenized [OPG study]6.720868
GSM549118patient 074, normal, homogenized [OPG study]9.6818492
GSM549129patient 027, cancer, homogenized [OPG study]6.3276562
GSM549123patient 088, normal, homogenized [OPG study]9.7149392
GSM549124patient 006, cancer, homogenized [OPG study]6.5862867
GSM549126patient 015, cancer, homogenized [OPG study]7.7620679
GSM549128patient 025, cancer, homogenized [OPG study]6.5154165
GSM549103patient 117, normal, homogenized [OPG study]9.3100191
GSM549117patient 073, normal, homogenized [OPG study]9.225589
GSM549138patient 041, cancer, homogenized [OPG study]5.8285955
GSM549141patient 045, cancer, homogenized [OPG study]5.8828657
GSM549130patient 028, cancer, homogenized [OPG study]7.9677781
GSM549101patient 111, normal, homogenized [OPG study]8.7959388
GSM549105patient 128, normal, homogenized [OPG study]9.671693
GSM549106patient 134, normal, homogenized [OPG study]5.3531348
GSM549112patient 048, normal, homogenized [OPG study]9.5969192
GSM549125patient 011, cancer, homogenized [OPG study]6.9942472
GSM549127patient 024, cancer, homogenized [OPG study]7.3868375
GSM549135patient 035, cancer, homogenized [OPG study]6.6530467